Fanyi Mo, BS

Research Lab Technician I
Center for Craniofacial Molecular Biology
Herman Ostrow School of Dentistry of USC

2250 Alcazar St.
CSA 210 – HSC 9062
Los Angeles, CA 90033-9062
Phone: (323) 442-3170
Fax: (323) 442-2981
fanyimo@usc.edu

Education
Experience
Publications

University of Wisconsin-Madison, Madison, Wisconsin
B.S., 2023
Biology

  • 2025 – present – Research Lab Technician I – Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, California

  • 2024 – 2025 – Research Associate – Inotiv (Drug Development Department) Bioproducts Site, Lafayette, Indiana

  • 2021 – 2024 – Research Assistant – UW CIPT Lab, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin

  1. Li Z, Wang Y, Mo F, Wolter T, Hong R, Barrett A, Richmond N, Liu F, Chen Y, Yang X, Dempsey L, Hu Q. Engineering pyroptotic vesicles as personalized cancer vaccines. Nat Nanotechnol. 2025 May 16. doi: 10.1038/s41565-025-01931-2. Epub ahead of print. PMID: 40379868.

  2. Li Z, Mo F, Guo K, Ren S, Wang Y, Chen Y, Schwartz PB, Richmond N, Liu F, Ronnekleiv-Kelly SM, Hu Q. (2024) Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer. Med. 2024 Apr 12;5(4):348-367.e7. doi: 10.1016/j.medj.2024.02.012. Epub 2024 Mar 22. PMID: 38521069.

  3. Mo F, Liu J, Chen G, Gong N, Li Z. (2023) Editorial: Nanotechnology and bioengineering platforms for drug and gene delivery. Front Bioeng Biotechnol. 2023 Nov 23;11:1328961. doi: 10.3389/fbioe.2023.1328961. PMID: 38076423; PMCID: PMC10704092.

  4. Wang Y, Li W, Li Z, Mo F, Chen Y, Iida M, Wheeler DL, Hu Q. (2023) Active recruitment of anti-PD-1-conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy. Sci Adv. 2023 Mar 29;9(13):eadf6854. doi: 10.1126/sciadv.adf6854. Epub 2023 Mar 29. PMID: 36989364; PMCID: PMC10058243.

  5. Wang Y, Li Z, Mo F, Chen-Mayfield TJ, Saini A, LaMere AM, Hu Q. (2023) Chemically engineering cells for precision medicine. Chem Soc Rev. 2023 Feb 6;52(3):1068-1102. doi: 10.1039/d2cs00142j. PMID: 36633324.

  6. Wang Y, Li Z, Chen Y, Barrett A, Mo F, Hu Q. (2023) Nano-STING agonist-decorated microrobots boost innate and adaptive anti-tumor immunity. Nano Res. 16, 9848–9858 (2023). https://doi.org/10.1007/s12274-023-5737-4.

  7. Li Z, Deng Y, Sun H, Tan C, Li H, Mo F, Wang Y, Li J, Zhou Z, Sun M. (2023) Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity. J Control Release. 2023 Jun;358:579-590. doi: 10.1016/j.jconrel.2023.05.013. Epub 2023 May 19. PMID: 37172908.

  8. Li Z, Mo F, Wang Y, Li W, Chen Y, Liu J, Chen-Mayfield TJ, Hu Q. (2022) Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nat Commun. 2022 Oct 24;13(1):6321. doi: 10.1038/s41467-022-34036-8. PMID: 36280674; PMCID: PMC9592600.

  9. Li Z, Ding Y, Liu J, Wang J, Mo F, Wang Y, Chen-Mayfield TJ, Sondel PM, Hong S, Hu Q. (2022) Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment. Nat Commun. 2022 Apr 6;13(1):1845. doi: 10.1038/s41467-022-29388-0. PMID: 35387972; PMCID: PMC8987059.

  10. Wang Y, Li Z, Mo F, Gu Z, Hu Q. (2021) Engineered platelets: Advocates for tumor immunotherapy. Nano Today. 40. 101281. 10.1016/j.nantod.2021.101281.